Cogent Biosciences annual operating expenses
2017
2018
2019
2020
2022
2023
2024
2025
Cogent Biosciences Operating Expenses Growth & History (COGT)
Cogent Biosciences's operating expenses was $333.4M for fiscal 2025.
View full Cogent Biosciences company overviewCogent Biosciences annual operating expenses history
| Fiscal year | Period ended | Operating expenses | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $333.4M | $57.4M | +20.81% |
| 2024 | 2024-12-31 | $275.9M | $67.8M | +32.58% |
| 2023 | 2023-12-31 | $208.1M | $60.3M | +40.78% |
| 2022 | 2022-12-31 | $147.8M | — | — |
| 2020 | 2020-12-31 | $90.1M | $35.4M | +64.73% |
| 2019 | 2019-12-31 | $54.7M | $8.9M | +19.54% |
| 2018 | 2018-12-31 | $45.7M | $11.2M | +32.53% |
| 2017 | 2017-12-31 | $34.5M | — | — |
Cogent Biosciences quarterly operating expenses
Q1.17
Q2.17
Q3.17
Q4.17
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Operating expenses | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $102.6M | $27.1M | +35.80% |
| Q1 2026 | 2026-03-31 | $103.6M | $28.7M | +38.27% |
| Q4 2025 | 2025-12-31 | $99.5M | — | — |
| Q3 2025 | 2025-09-30 | $83.4M | — | — |
| Q2 2025 | 2025-06-30 | $75.6M | — | — |
| Q1 2025 | 2025-03-31 | $74.9M | — | — |
| Q4 2020 | 2020-12-31 | $11.5M | −$1.6M | −12.20% |
| Q3 2020 | 2020-09-30 | $57.5M | $44.5M | +340.49% |
| Q2 2020 | 2020-06-30 | $7.9M | −$5.7M | −42.02% |
| Q1 2020 | 2020-03-31 | $13.2M | −$1.7M | −11.56% |
| Q4 2019 | 2019-12-31 | $13.0M | $239,000 | +1.87% |
| Q3 2019 | 2019-09-30 | $13.1M | $437,000 | +3.46% |
| Q2 2019 | 2019-06-30 | $13.7M | $2.6M | +23.18% |
| Q1 2019 | 2019-03-31 | $14.9M | $5.7M | +61.79% |
| Q4 2018 | 2018-12-31 | $12.8M | $3.8M | +42.27% |
| Q3 2018 | 2018-09-30 | $12.6M | $3.1M | +32.82% |
| Q2 2018 | 2018-06-30 | $11.1M | $3.0M | +36.90% |
| Q1 2018 | 2018-03-31 | $9.2M | $1.3M | +16.59% |
| Q4 2017 | 2017-12-31 | $9.0M | — | — |
| Q3 2017 | 2017-09-30 | $9.5M | — | — |
| Q2 2017 | 2017-06-30 | $8.1M | — | — |
| Q1 2017 | 2017-03-31 | $7.9M | — | — |
Cogent Biosciences operating expenses trends
Over the last five fiscal years, Cogent Biosciences's operating expenses increased from $90.1M to $333.4M, a change of $243.3M. The latest reported quarter, Q2 2026, shows $102.6M.
About the metric
What operating expenses mean
Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.
Calculation and source
SEC-reported and calculated operating expenses
TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Cogent Biosciences source filings ↗